FDA Drug Recalls

Recalls / Class I

Class ID-0277-2024

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

FentaNYL citrate PF, 1000 mcg per 100 mL 0.9% Sodium Chloride (10 mcg per mL), Item F3355, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-072-41.

Affected lot / code info
Lot #: 2331062, Exp. Date: 02/08/2024; 2331224, Exp. Date 03/18/2024; 2331270, Exp. Date 03/28/2024.

Why it was recalled

Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Recalling firm

Firm
Denver Solutions, LLC DBA Leiters Health
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
13796 Compark Blvd, Englewood, Colorado 80112-7145

Distribution

Quantity
8,976 IV bags
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2023-12-28
FDA classified
2024-01-29
Posted by FDA
2024-02-07
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0277-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: drug · FDA Drug Recalls